Bioengineered Nisin Derivative M17Q Has Enhanced Activity against Staphylococcus epidermidis

Antibiotics
Ellen TwomeyMáire Begley

Abstract

Staphylococcus epidermidis is frequently implicated in medical device-related infections. As a result of this, novel approaches for control of this opportunistic pathogen are required. We examined the ability of the natural peptide nisin A, produced by Lactococcus lactis, to inhibit S. epidermidis. In addition, a bank of 29 rationally selected bioengineered L. lactis strains were examined with the aim of identifying a nisin derivative with enhanced antimicrobial activity. Agar-based deferred antagonism assays revealed that wild type nisin A inhibited all 18 S. epidermidis strains tested. Larger zones of inhibition than those obtained from the nisin A producing L. lactis strain were observed for each derivative producer against at least one S. epidermidis strain tested. Six derivative producing strains, (VGA, VGT, SGK, M21A, M17Q, AAA), gave larger zones against all 18 strains compared to the wildtype producing strain. The enhanced bioactivity of M17Q was confirmed using well diffusion, minimum inhibitory concentration (MIC) and a broth-based survival assays. Biofilm assays were performed with plastic microtiter plates and medical device substrates (stainless-steel coupons and three catheter materials). The presence of nisin A s...Continue Reading

References

Nov 1, 1991·European Journal of Biochemistry·J W MuldersW M de Vos
Jan 1, 1982·Annals of Internal Medicine·G D ChristensenR W Luther
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·W M DunneS L Kaplan
May 4, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R GhiselliV Saba
May 27, 2005·Antimicrobial Agents and Chemotherapy·Kimberly K JeffersonGerald B Pier
Feb 8, 2006·Applied and Environmental Microbiology·Ruth E WirawanJohn R Tagg
Apr 21, 2009·Ultramicroscopy·Zhiqiang QinJens Ulstrup
May 12, 2010·Antimicrobial Agents and Chemotherapy·William M DavisonPhilip S Stewart
Jan 21, 2012·Microbial Biotechnology·Susan RouseR Paul Ross
Feb 1, 2012·International Journal of Microbiology·Clare PiperR Paul Ross
Feb 5, 2013·BMC Microbiology·Alicia CampionR Paul Ross
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·Ken-ichi OkudaYoshimitsu Mizunoe
Dec 1, 2009·The Journal of the American College of Certified Wound Specialists·Colin BradfordSteven L Percival
Mar 6, 2015·Frontiers in Cellular and Infection Microbiology·Henning BüttnerHolger Rohde
May 15, 2015·Bioengineered·Des FieldColin Hill
Dec 8, 2015·Frontiers in Microbiology·Des FieldR P Ross
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Anton Du Preez van StadenLeon M T Dicks
Jun 17, 2016·Scientific Reports·Hui-Wen ChenChun-Ming Huang
Jan 25, 2018·Nature·Y Erin ChenYasmine Belkaid
May 1, 2018·NPJ Biofilms and Microbiomes·Harsh MathurR Paul Ross
Jun 9, 2018·American Journal of Clinical Dermatology·Nicola E Natsis, Philip R Cohen
Sep 5, 2018·Nature Microbiology·Jean Y H LeeBenjamin P Howden
Sep 29, 2018·Nature Communications·João Medeiros-SilvaMarkus Weingarth
Jul 10, 2019·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Michelle V MouritzenHåvard Jenssen

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM17

Methods Mentioned

BETA
NMR
scrapings
Assay

Software Mentioned

MS Excel

Related Concepts

Related Feeds

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

© 2022 Meta ULC. All rights reserved